← Evidence map

ReviewInternational urology and nephrology2020

Sclerostin: a new biomarker of CKD-MBD.

Andreja Figurek et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

27 papers cite it

2019
2020
2021
2022
2023
2024
2025
this papercites it

The trial

NCT0768522330 enrolled2026
Full record →Abstract, authors, funding and every citing paper · PMID 31612420